Magic mushrooms.
A prospective randomized phase 2 trial of 233 patients with treatment-refractory depression demonstrates a significant improvement at 3 weeks with a single 25 mg dose of psilocybin. | Goodwin, N Engl J Med 2022
With increasing information overload and packed work schedules, staying up-to-date on the newest oncologic advances is harder than ever. But take heart! The QuadShot is freshly brewed in your inbox four mornings each week so you can quickly down and digest the day's most pertinent cancer news.
A prospective randomized phase 2 trial of 233 patients with treatment-refractory depression demonstrates a significant improvement at 3 weeks with a single 25 mg dose of psilocybin. | Goodwin, N Engl J Med 2022
Comments
Post a Comment